The impact of different antibiotic regimens on the emergence of antimicrobial-resistant bacteria

PLoS ONE

Volumn 3, Issue 12, 2008, Pages

  D'Agata, Erika M C ^a   Dupont Rouzeyrol, Myrielle ^b   Magal, Pierre ^c   Olivier, Damien ^b   Ruan, Shigui ^d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITÉ DU HAVRE   (France)

^c UNIVERSITÉ DU HAVRE   (France)

^d Department of Biology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; MULTIDRUG RESISTANCE PROTEIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DRUG EXPOSURE; IMMUNE RESPONSE; MATHEMATICAL MODEL; NONHUMAN; SHORT COURSE THERAPY; SIMULATION; TREATMENT DURATION; TREATMENT WITHDRAWAL; ALGORITHM; BACTERIUM; BIOLOGICAL MODEL; DRUG EFFECT; GENE TRANSFER; GENETICS; HUMAN; IMMUNE SYSTEM; INFECTION CONTROL; METABOLISM; MICROBIOLOGICAL EXAMINATION; MULTIDRUG RESISTANCE; PLASMID; THEORETICAL MODEL;

BACTERIA (MICROORGANISMS);

ALGORITHMS; ANTI-BACTERIAL AGENTS; BACTERIA; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENE TRANSFER TECHNIQUES; HUMANS; IMMUNE SYSTEM; INFECTION CONTROL; MICROBIAL SENSITIVITY TESTS; MODELS, BIOLOGICAL; MODELS, THEORETICAL; PLASMIDS;

EID: 58149193216     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0004036     Document Type: Article

References (50)

1. Cassel GH, Mekalanos J (2001) Development of antimicrobial agents in the era of new and reemerging infectious diseases and increasing antibiotic resistance. JAMA 285: 601-605.
2. Levy SB, Marshall B (2004) Antibacterial resistance worldwide: Causes, challenges and responses. Nat Med 10: S122-S129.
3. Spellberg B, et al. (2008) The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clin Infect Dis 46: 155-164.
4. Siegel JD, Rhinehart E, Jackson M, Chiarello L (2007) Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control 35: S165-193.
5. Daxboeck F, et al. (2006) Economic burden associated with multi-resistant Gram-negative organisms compared with that for methicillin-resistant Staphylococcus aureus in a university teaching hospital. J Hosp Infect 62: 214-218.
6. Schwaber MJ, et al. (2006) Clinical and economic impact of bacteremia with extended- spectrum-beta-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother 50: 1257-1262.
7. Institute of Medicine (1998) Antimicrobial Resistance: Issues and Options. Washingto DC: National Academic Press.
8. Klevens RM, et al. (2007) Invasive methicillin-resistant Staphylococcu aureus infections in the United States. JAMA 298: 1763-1771.
9. Austin DJ, Anderson RM (1999) Studies of antibiotic resistance within the patient, hospitals and the community using simple mathematical models. Phil Trans R Soc Lond B 354: 721-738.
10. Bonhoeffer S, Liptsitch M, Levin BR (1997) Evaluating treatment protocols to prevent antibiotic resistance. Proc Natl Acad Sci USA 94: 12106-12111.
11. Bergstrom CT, Lo M, Lipsitch M (2004) Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals. Proc Natl Acad Sci USA 101: 13285-13290.
12. D'Agata EMC, Magal P, Olivier D, Ruan S, Webb GF (2007) Modeling antibiotic resistance in hospitals: The impact of minimizing treatment duration. J Theor Biol 249: 487-499.
13. Boldin B, Bonten MJ, Diekmann O (2007) Relative effects of barrier precautions and topical antibiotics on nosocomial bacterial transmission: Results of multi-compartment models. Bull Math Biol 69: 2227-2248.
14. Consortium REX (2007) Structure of the scientific community modelling the evolution of resistance. PLoS ONE 2(12): e1275. doi:10.1371/journal. pone.0001275.
15. Temime L, et al. (2008) The rising impact of mathematical modeling in epidemiology: Antibiotic resistance research as a case study. Epidemiol Infec 136: 289-298.
16. Webb GF, D'Agata EMC, Magal P, Ruan S (2005) A model of antibiotic-resistant bacterial epidemics in hospitals. Proc Natl Acad Sci USA 102: 13343-13348.
17. Bonten MJM, Austin DJ, Lipsitch M (2001) Understanding the spread of antibiotic resistant pathogens in hospitals: mathematical models as tools for control. Clin Infect Dis 33: 1739-1746.
18. Grundmann H, Hellriegel B (2006) Mathematical modeling: A tool for hospital infection control. Lancet Infect Dis 6: 39-45.
19. Levin BR (2001) Minimizing potential resistance: A population dynamics view. Clin Infect Dis 33: S161-S169.
20. Austin DJ, White NJ, Anderson RM (1998) The dynamics of drug action on the within-host population growth of infectious agents: melding pharmacokinetics with pathogen population dynamics. J Theoret Biol 194: 313-339.
21. Imran M, Smith HL (2007) The dynamics of bacterial infection, innate immune response and antibiotic treatment. Discrete Cont Dynamical Systems B 8: 127-143.
22. Lipsitch M, Levin BR (1997) The population dynamics of antimicrobial chemotherapy. Antimicrob Agent Chemother 41: 363-373.
23. Levin BR, Rozen DE (2006) Non-inherited antibiotic resistance. Nat Rev Microbiol 4: 556-562.
24. Smets BF, Barkay T (2005) Horizontal gene transfer: Perspectives at a crossroads of scientific disciplines. Nat Rev Microbiol 3: 675-678.
25. Walsh C (2000) Molecular mechanisms that confer antibacterial drug resistance. Nature 406: 775-781.
26. Monack DM, Mueller A, Falkow S (2004) Persistent bacterial infections: The interface of pathogen and the host immune system. Nat Rev Microbiol 2: 747-765.
27. Freter R, et al. (1983) Survival and implantation of Escherichia coli in the intestinal tract. Infect Immun 39: 686-703.
28. Gibbons RJ, Kapsimalis B (1967) Estimates of the overall rate of growth of the intestinal microflora of hamsters, guinea pigs, and mice. J Bacteriol 93: 510-512.
29. Hartl DL, Dykhuizen DE (1984) The population genetics of Escherichia coli. Annu Rev Genet 18: 31-68.
30. Pilyugin SS, Antia R (2000) Modeling immune response with handling time. Bull Math Biol 62: 869-890.
31. Poulsen LK, et al. (1995) Physiological state of Escherichia coli BJ4 growing in the large intestines of streptomycin-treated mice. J Bacteriol 177: 5840-5845.
32. Sorensen TL, et al. (2001) Transient intestinal carriage after ingestion of antibiotic-resistant Enterococcus faecium from chicken and pork. N Engl J Med 345: 1161-1166.
33. Bahl MI, et al. (2004) Quantification of plasmid loss in Escherichia coli cells by use of flow cytometry. FEMS Microbiol Lett 232: 45-49.
34. Haneda T, Okada N, Miki T, Danbara H (2004) Sequence analysis and characterization of sulfonamide resistance plasmid pRF-1 from Salmonella enterica serovar Choleraesuis. Plasmid 52: 218-224.
35. Sorensen SJ, et al. (2005) Studying plasmid horizontal transfer in situ: a critical review. Nat Rev Microbiol 3: 700-710.
36. Smith MA, Bidochka MJ (1998) Bacterial fitness and plasmid loss: the importance of culture conditions and plasmid size. Can J Microbiol 44: 351-355.
37. Dutta C, Pan A (2002) Horizontal gene transfer and bacterial diversity. J Biosci 27: 27-33.
38. Leverstein-van Hall MA, et al. (2003) Multidrug resistance among Enterobacteriaceae is strongly associated with the presence of integrons and is independent of species or isolate origin. J Infect Dis 187: 251-259.
39. Livermore DM, et al. (2007) CTX-M: changing the face of ESBLs in Europe. J Antimicrob Chemother 59: 165-174.
40. Walsh TR (2005) The emergence and implications of metallo-beta-lactamases in Gram-negative bacteria. Clin Microbiol Infect 11(Suppl 6): 2-9.
41. Kurland GC, Canback B, Berg OG (2003) Horizontal gene transfer: a critical view. Proc Natl Acad Sci USA 100: 9658-9662.
42. Spratt BG, Hanage WP, Feil EJ (2001) The relative contributions of recombination and point mutation to the diversification of bacterial clones. Curr Opin Microbiol 4: 602-606.
43. Waters VL (1999) Conjugative transfer in the dissemination of beta-lactam and aminoglycoside resistance. Front Biosci 4: D433-456.
44. Lenski RE (1998) Bacterial evolution and the cost of antibiotic resistance. Int Microbiol 1: 265-270.
45. Nordstrom K (2006) Plasmid R1-replication and its control. Plasmid 55: 1-26.
46. Nordstrom K, Aagaard-Hansen H (1984) Maintenance of bacterial plasmids: comparison of theoretical calculations and experiments with plasmid R1 in Escherichia coli. Mol Gen Genet 197: 1-7.
47. Dellit TH, et al. (2007) Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 44: 159-177.
48. Cottarel G, Wierzbowski J (2007) Combinatioon drugs, an emerging option for antibacterial therapy. TRENDS Biotechnol 25: 547-555.
49. Lipsitch M, Bergstrom CT (2002) Modeling of antibiotic resistance in the ICU-U.S. slant. In: Infection Control in the ICU Environment. RA Weinstein, M Benten, eds. Dordrecht, The Netherlands: Kluwer. pp 1-16.
50. Reluga TC (2005) Simple models of antibiotic cycling. Math Med Biol 22: 187-208.